CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Net Cash Flow Growth by Quarter and Year

Mateon Therapeutics Inc's Net Cash Flow results by quarter and year




OXGN Net Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 0.08 1.73 -1.04
III Quarter September - - -0.88 2.51
II Quarter June 0.48 0.06 -0.79 -4.40
I Quarter March 0.10 -0.91 -3.10 -2.34
FY   0.58 -0.77 -3.04 -5.27



OXGN Net Cash Flow second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc achieved in the second quarter, above Company average Net Cash Flow surge of 695.78% year on year, to $ 0.48 millions.

Looking into second quarter results within Biotechnology & Drugs industry 17 other companies have achieved higher Net Cash Flow growth. While Mateon Therapeutics Inc' s Net Cash Flow doubling of 695.78% ranks overall at the positon no. 319 in the second quarter.




OXGN Net Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -95.38 % - -
III Quarter September - - - -
II Quarter June 695.78 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 Net Cash Flow $ 0.48 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 Net Cash Flow $ 0.06 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Net Cash Flow Growth >>


OXGN Net Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 377.47 % - - -
I Quarter March 25 % - - -
FY (Year on Year)   - - - -




Net Cash Flow second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #18
Healthcare Sector #61
Overall #319

Net Cash Flow Y/Y Growth Statistics
High Average Low
370.54 % 9.04 % -100 %
(Jun 30 2020)   (Sep 30 2019)
Net Cash Flow second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #18
Healthcare Sector #61
Overall #319
Net Cash Flow Y/Y Growth Statistics
High Average Low
370.54 % 9.04 % -100 %
(Jun 30 2020)   (Sep 30 2019)

Net Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
370.54 % 9.04 % -100 %
(Jun 30 2020)  


OXGN's II. Quarter Q/Q Net Cash Flow Comment
Mateon Therapeutics Inc achieved in the II. Quarter 2020 above company average sequential Net Cash Flow doubling of 377.47%, to $ 0.48 millions, from $0.10 millions in the first quarter.
Biotechnology & Drugs company is going from strength to strength, not just claiming above regular gain, and also improving pace.

Within Biotechnology & Drugs industry 17 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Mateon Therapeutics Inc's Net Cash Flow growth quarter on quarter, overall rank is 319.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #18
Healthcare Sector #61
Overall #319
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #18
Healthcare Sector #61
Overall #319
Net Cash Flow Q/Q Growth Statistics
High Average Low
370.54 % 9.04 % -100 %
(Jun 30 2020)  


OXGN's II. Quarter Q/Q Net Cash Flow Comment
Mateon Therapeutics Inc achieved in the II. Quarter 2020 above company average sequential Net Cash Flow doubling of 377.47%, to $ 0.48 millions, from $0.10 millions in the first quarter.
Biotechnology & Drugs company is impressively improving, not just claiming better then regular gain, and additionally improving pace.

Within Biotechnology & Drugs industry 17 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Mateon Therapeutics Inc's Net Cash Flow growth quarter on quarter, overall rank is 319.


Mateon Therapeutics Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Net Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Jun 30 2020 period, Mateon Therapeutics Inc's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Jun 30 2020 period, Mateon Therapeutics Inc's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Biotechnology & Drugs Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
OXGN's Net Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for OXGN's Competitors
Net Cash Flow Growth for Mateon Therapeutics Inc's Suppliers
Net Cash Flow Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jun 30 2020
Fennec Pharmaceuticals Inc   1,177.53 %$ 1,177.529 millions
Utah Medical Products Inc  1,173.95 %$ 1,173.953 millions
Alpine Immune Sciences Inc   1,170.05 %$ 1,170.046 millions
Menlo Therapeutics Inc   1,155.15 %$ 1,155.150 millions
Chromadex Corporation  1,119.86 %$ 1,119.861 millions
Geovax Labs Inc   1,109.31 %$ 1,109.308 millions
Aeglea Biotherapeutics Inc   1,088.61 %$ 1,088.610 millions
Tricida Inc   992.54 %$ 992.541 millions
Bioanalytical Systems Inc  986.96 %$ 986.957 millions
Assembly Biosciences inc   955.78 %$ 955.776 millions
Arena Pharmaceuticals Inc   842.76 %$ 842.761 millions
American Cannabis Company Inc   835.98 %$ 835.978 millions
Allyme Group Inc   796.59 %$ 796.586 millions
Dyadic International Inc   779.26 %$ 779.260 millions
Zomedica Pharmaceuticals Corp   740.03 %$ 740.030 millions
Mateon Therapeutics Inc  737.66 %$ 737.660 millions
Immunic Inc   705.28 %$ 705.283 millions
National Healthcare Corp  672.72 %$ 672.722 millions
Diamedica Therapeutics Inc   669.77 %$ 669.767 millions
Iovance Biotherapeutics inc   640.93 %$ 640.928 millions
Mymetics Corp  634.96 %$ 634.959 millions
Haemonetics Corp  562.81 %$ 562.807 millions
Ibio Inc   553.50 %$ 553.502 millions
Allakos Inc   541.97 %$ 541.974 millions
Perrigo Company Plc  496.33 %$ 496.327 millions
Atricure Inc   479.93 %$ 479.932 millions
Techcare Corp   444.45 %$ 444.446 millions
Catalent Inc   417.28 %$ 417.277 millions
Myriad Genetics Inc   414.46 %$ 414.458 millions
Chembio Diagnostics Inc   388.75 %$ 388.748 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LTRX's Profile

Stock Price

LTRX's Financials

Business Description

Fundamentals

Charts & Quotes

LTRX's News

Suppliers

LTRX's Competitors

Customers & Markets

Economic Indicators

LTRX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071